Search Results - "Maspero, J"

Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America by Katelaris, C. H., Lee, B. W., Potter, P. C., Maspero, J. F., Cingi, C., Lopatin, A., Saffer, M., Xu, G., Walters, R. D.

“…Background There is comparatively little information in the public domain on the diversity in prevalence and triggers/factors associated with allergic rhinitis…”
Get full text

Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy by Parisi, C. A. S., Smaldini, P. L., Gervasoni, M. E., Maspero, J. F., Docena, G. H.

“…Summary Background The Sabin vaccine is used world‐wide, and most children with food allergies receive it without incident. However, in the 2009 vaccination…”
Get full text

Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies by Maspero, Jorge F, Bachert, Claus, Martinez, Fernando J, Hanania, Nicola A, Ortiz, Benjamin, Patel, Naimish, Mannent, Leda P, Praestgaard, Amy, Pandit-Abid, Nami, Siddiqui, Shahid, Hardin, Megan

“…To provide a descriptive summary of clinical efficacy and health-related quality of life (HRQoL) measures in patients with chronic rhinosinusitis with nasal…”
Get full text

Similar biological activity in skin prick test for Oralair® (8200 BAU) and Grazax® (6200 BAU) reinforces effective SLIT dosing level by Larenas Linnemann, D. E. S., Singh, J., Rosario, N., Esch, R., Matta, J. J., Maspero, J., Michels, A., Mösges, R.

“…In Europe, allergen extracts are standardized based on skin prick wheal size in 20–30 allergic subjects. To understand the biological activity of clinically…”
Get full text

Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States by Maspero, J., Lee, B. W., Katelaris, C. H., Potter, P. C., Cingi, C., Lopatin, A., Saffer, M., Nadeau, G., Walters, R. D.

“…Summary There is comparatively little information on health‐related quality of life (HRQoL) in subjects with allergic rhinitis (AR) or allergic…”
Get full text

12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis by Fantin, S, Maspero, J, Bisbal, C, Agache, I, Donado, E, Borja, J, Mola, O, Izquierdo, I

“…With the current increasing incidence of allergies worldwide, new treatments showing efficacy and long term safety are needed for chronic conditions such as…”
Get full text

Long-term Safety of Medium- and High-Doses Mometasone Furoate/Formoterol Combination in Persistent Asthmatics: Analysis of Adverse Events Incidence, Plasma Cortisol, and Ocular Changes by Maspero, J, Nolte, H, Ojeda, I. Cherrez

“…The incidence and severity of AEs, plasma cortisol 24-hour area under the curve (AUC), changes in lens opacities classification system, and intraocular…”
Get full text

Long-term Safety and Tolerability of Two Doses of Mometasone Furoate/Formoterol (MF/F) Combination, Administered Via a Metered-dose Inhaler, for the Treatment of Moderate-to-severe Persistent Asthma by Maspero, J, Cherrez, I, Nolte, H

“…Patients (>=12 years) with moderate-to-severe persistent asthma previously treated with medium- to high-dose inhaled corticosteroids were randomized to…”
Get full text

Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial by Maspero, Jorge F, Khan, Asif H, Philpott, Carl, Hellings, Peter W, Hopkins, Claire, Wagenmann, Martin, Siddiqui, Shahid, Msihid, Jérôme, Nash, Scott, Chuang, Chien-Chia, Kamat, Siddhesh, Rowe, Paul J, Deniz, Yamo, Jacob-Nara, Juby A

“…Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammatory disease with a high symptom burden. Data are lacking on the…”
Get full text

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization by Corren, Jonathan, Jackson, David J, Casale, Thomas B, Borish, Larry, Rabe, Klaus F, Busse, William W, Maspero, Jorge F, Jackson, Daniel J, Daizadeh, Nadia, Altincatal, Arman, Radwan, Amr, Khodzhayev, Angela, Djandji, Michel, Jacob-Nara, Juby A, Rowe, Paul J, Deniz, Yamo

“…Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for interleukins-4/-13, key and central drivers of type 2 (T2) inflammation…”
Get full text

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation by Hanania, Nicola A, Maspero, Jorge F, Halpin, David MG, Jackson, David J, Panettieri, Reynold A, Castro, Mario, Domingo, Christian, Daizadeh, Nadia, Gall, Rebecca, Jacob-Nara, Juby A, Ortiz, Benjamin, Djandji, Michel, Rowe, Paul J, Deniz, Yamo

“…Nicola A Hanania,1 Jorge F Maspero,2 David MG Halpin,3 David J Jackson,4,5 Reynold A Panettieri,6 Mario Castro,7 Christian Domingo,8 Nadia Daizadeh,9 Rebecca…”
Get full text

Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy by Maspero, J F, Dueñas-Meza, E, Volovitz, B, Pinacho Daza, C, Kosa, L, Vrijens, F, Leff, J A

“…This 6-month, open-label extension study of a previously described base study compared oral montelukast with inhaled beclomethasone in terms of safety, forced…”
Get full text

Ciclesonide, Administered Once Daily, has No Effect on Growth Velocity in Prepubertal Children with Mild, Persistent Asthma by Skoner, D., Maspero, J., Kundu, S., Lloyd, M., Banerji, D.

“…Ciclesonide, a novel ICS, showed no detectable impact on growth in children with asthma and is a safe treatment option for pediatric asthma management…”
Get full text

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma by Castro, Mario, Corren, Jonathan, Pavord, Ian D, Maspero, Jorge, Wenzel, Sally, Rabe, Klaus F, Busse, William W, Ford, Linda, Sher, Lawrence, FitzGerald, J. Mark, Katelaris, Constance, Tohda, Yuji, Zhang, Bingzhi, Staudinger, Heribert, Pirozzi, Gianluca, Amin, Nikhil, Ruddy, Marcella, Akinlade, Bolanle, Khan, Asif, Chao, Jingdong, Martincova, Renata, Graham, Neil M.H, Hamilton, Jennifer D, Swanson, Brian N, Stahl, Neil, Yancopoulos, George D, Teper, Ariel

“…Treatment of uncontrolled asthma with dupilumab, an anti–interleukin-4 and anti–interleukin-13 receptor monoclonal antibody, in addition to usual therapy, led…”
Get full text

Safety profile of fluticasone propionate HFA in pre-school age children with asthma by Qaqundah, P.Y., Maspero, J., Ceruti, E., Scott, C.A., Clements, D.S., Wu, W., Crim, C.

“…Safety assessments included: adverse events (AEs), clinical labs, oropharyngeal/nasal exams, asthma exacerbations, and 12-hour, overnight urinary cortisol…”
Get full text

LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA: LIBERTY ASTHMA EXCURSION by Bacharier, L., Maspero, J., Katelaris, C., Fiocchi, A., Gagnon, R., De Mir-Messa, I., Lederer, D., Robinson, L.

“…Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for IL-4/IL-13. Efficacy and safety of dupilumab in children with asthma…”
Get full text

CO87 Reductions in Exacerbations and Improvements in Lung Function and Asthma Control in Children With Moderate-to-Severe Type 2 Asthma Analyzed by High- or Medium-Dose of Inhaled Corticosteroids at Baseline by Maspero, J, Antila, MA, Jain, N, Deschildre, A, Bacharier, LB, Altincatal, A, Laws, E, Akinlade, B, Siddiqui, S, Jacob-Nara, JA, Deniz, Y, Rowe, PJ, Lederer, DJ, Hardin, M

Get full text

P503 MEPOLIZUMAB FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: COMORBID ASTHMA, NSAID EXACERBATED RESPIRATORY DISEASE, EOSINOPHIL STRATIFICATION by Bachert, C., Sousa, A., Han, J., Schlosser, R., Sowerby, L., Hopkins, C., Maspero, J., Kante, O., Karidi-Andrioti, D., Chaker, A.

Get full text

P219 DUPILUMAB IS WELL TOLERATED AND SHOWS SUSTAINED EFFICACY IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE by Wechsler, M., Ford, L., Maspero, J., Pavord, I., Langton, D., Domingo, C., Papi, A., Bourdin, A., Watz, H., Amin, N., Hardin, M.

Get full text

PCR53 Efficacy of Dupilumab in Patients with Uncontrolled, Moderate-to-Severe Asthma and with High Sleep Disturbance: A Post Hoc Analysis from Liberty Asthma Quest by Maspero, J, Shafazand, S, Cole, J, Pavord, ID, Busse, WW, Msihid, J, Gall, R, Soler, X, Siddiqui, S, Khan, AH, Gómez, LDP, Jacob-Nara, JA

Get full text